This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stock Market Today: Dow Jones Futures Are Down.

TheStreet's SpeedDesk Pre-Market Newsletter

Monday, April 7, 2014


As of 8:45 a.m., the Dow Jones futures were down -50.00, the S&P futures were down -7.20, and the Nasdaq futures were down -29.00.

Here's Why: U.S. stocks were set for a lower open today, putting the S&P 500 on track for its third straight decline, as weakness in momentum names that sent the Nasdaq and benchmark S&P index to their worst drop since February in the prior session appeared poised to continue.


In Europe, the FTSE 100 Index was down -54.98, the CAC 40 Index was down -33.68, and the Deutsche Boerse AG German Stock Index DAX was down -148.50.

Here's why: European equities retreated on Monday after a three-week rally, with technology shares falling the most on concern they had advanced too far, too fast and a correction was due.

In Asia, the Nikkei 225 fell -254.92 and the Hong Kong Hang Seng Index closed down -132.93.

Here's why: Japan's Nikkei share average fell to a one-week low today, dragged down by tech shares following a slide on Wall Street, while a strong yen hit exporters to round out a harsh day for the market. 


Cement makers Holcim (HCMLY) and Lafarge (LFRGY) have agreed to an all-share merger of equals that will create a company with over $40 billion in annual sales and a market cap of $50 billion.

Vivendi (VIVHY) will sell its SFR unit to Luxembourg-based cable and mobile provider Altice despite Bouygues sweetening its offer for the mobile business at the last minute. Altice will give Vivendi a 20% stake in a company that will be created via the merger of SFR and Altice's French Numericable subsidiary. The entire deal is worth $23.3 billion.

Sun Pharmaceutical Industries will acquire Ranbaxy Laboratories (RBXLY) for $3.2 billion in an all-stock deal that will create the world's fifth-largest generic-drug maker Ranbaxy, which is owned by Japan's Daiichi Sankyo (DSKYF) banned from selling ingredients to the U.S., while Sun's Karkhadi facility is also not allowed to export products to the U.S.


Yahoo (YHOO) plans to acquire original programming usually seen on high-end cable-TV networks and streaming services like Netflix (NFLX), the Wall Street Journal reports

Mallinckrodt (MNK) will buy Questcor Pharmaceuticals (QCOR) for $5.6 billion to add specialty drugs in the latest industry deal that moves a U.S. company to Ireland for a lower tax rate, Bloomberg reports

Energen Corp. (EGN) agreed to sell its Alabama natural gas utility to the Laclede Group (LG) for $1.28 billion in cash, Bloomberg reports

Caterpillar (CAT) is likely to face tougher scrutiny from the IRS after being grilled over its tax strategies at a U.S. Senate subcommittee hearing last week, some tax experts say, the Wall Street Journal reports

Credit Suisse (CS) faces the threat of a new investigation into its role in helping wealthy Americans avoid paying taxes after New York state's top financial regulator requested documents from the Swiss bank, Reuters reports


No IPOs are expected to price on Monday.


After today's market close, notable earnings include: A Schulman (SHLM), Novagold Resources (NG), and Genco Shipping & Trading (GNK)

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,031.14 +43.63 0.26%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs